The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 21, 2014
Filed:
Nov. 09, 2012
Applicant:
Allergan, Inc., Irvine, CA (US);
Inventors:
Jeffrey L. Edelman, Irvine, CA (US);
Alissar Nehme, Mission Viejo, CA (US);
Assignee:
Allergan, Inc., Irvine, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/56 (2006.01); A61K 31/575 (2006.01); C07J 7/00 (2006.01); C07J 17/00 (2006.01); C07J 31/00 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
C07J 7/008 (2013.01); C07J 17/00 (2013.01); C07J 31/006 (2013.01); A61K 31/56 (2013.01); A61K 9/0048 (2013.01); A61K 31/575 (2013.01);
Abstract
The present invention relates to pharmaceutical compositions comprising 4-pregenen-11β-17-21-triol-3,20-dione derivatives, and their use as pharmaceuticals as modulators of the glucocorticoid receptors (GR) and/or the mineralocorticoid receptors (MR). The invention relates specifically to the use of these compounds and their pharmaceutical compositions to treat ocular conditions associated with the glucocorticoid receptors (GR) and/or the mineralocorticoid receptors (MR).